As tenders become an increasingly important commercial lever for pharmaceutical companies, AI and tender technologies are raising expectations around speed, consistency, and decision quality.
According to Simon-Kucher’s 2026 Tender Excellence industry study, 70% of respondents ranked AI as the most important trend shaping tender management. However, many pharma companies still lack a structured approach to tender strategy and landscape assessment.
Join our Simon-Kucher experts as they share exclusive insights from interviews with industry leaders across innovative pharma, generics, and biosimilars in Europe and Asia. Discover how leading organizations are moving beyond fragmented, reactive tendering to build more strategic and scalable capabilities, and where AI can create real value across the end-to-end tender process.
The webinar will cover:
- How tender exposure and procurement trends are reshaping the role of tender management
- Where AI and automation can create tangible value
- What foundations need to be in place for technology and AI to deliver impact
- How to build a practical process, data, and systems roadmap that drives lasting impact
This webinar is free of charge. Don’t miss the opportunity to gain insights into where to start, which tender capabilities to prioritize, and how to sequence investments in process, data, systems, and AI to build a more competitive and scalable tender organization.
Event details:
Tuesday, September 8, 2026: 3:00 - 4:00 p.m. CEST | 9:00 - 10:00 a.m. EDT
